+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Liraglutide Injection Market - Global Forecast 2026-2032- Product Image
Liraglutide Injection Market - Global Forecast 2026-2032- Product Image
Sale

Liraglutide Injection Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6144214
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Liraglutide Injection Market is projected to reach USD 8.19 Billion in 2026. It is expected to continue growing at a CAGR of 7.61%, reaching USD 12.68 Billion by 2032.

Liraglutide Injection: Executive Overview

Liraglutide injection is a prescription glucagon-like peptide-1 receptor agonist used in clinically established pathways for type 2 diabetes and, at specific approved doses and patient criteria, chronic weight management. Its market context is shaped by treatment guidelines, product labeling, reimbursement rules, injection-device usability, supply reliability, and ongoing scrutiny of safety, quality, and appropriate use. Demand is therefore closely tied to diagnosed disease, clinician prescribing practices, patient persistence, and access to follow-up care rather than to a single therapeutic indication.

How Care Pathways Are Reshaping Liraglutide Use

The landscape is shifting from isolated drug selection toward integrated cardiometabolic care. Clinicians increasingly evaluate glucose control, body weight, cardiovascular risk, kidney status, comorbidities, tolerability, and patient preferences together. This has increased the importance of titration support, adherence counseling, cold-chain handling, injection training, and continuity between primary care and specialist services. Competition from other therapeutic classes also makes differentiation depend on evidence, approved indications, affordability, dependable supply, and patient experience.

Artificial Intelligence Across the Liraglutide Value Chain

Artificial intelligence can strengthen demand identification, clinical decision support, pharmacovigilance, inventory planning, patient education, and operational quality control. Algorithms may help identify patients needing treatment review, flag potential adherence barriers, summarize real-world safety signals, and improve allocation of temperature-sensitive inventory. However, implementation requires clinically validated models, representative data, privacy safeguards, human oversight, explainability, and compliance with medical-device and pharmaceutical regulations. AI should support-not replace-prescriber judgment and individualized assessment.

Regional Insights: Access, Regulation, and Care Delivery

North America combines advanced diabetes and obesity-care infrastructure with strong emphasis on coverage policy, prior authorization, outcomes evidence, and medication-safety monitoring. Europe is shaped by national health-technology assessment, European Union regulatory coordination, country-level reimbursement, and structured primary-care pathways. Asia-Pacific spans highly diverse health systems, from sophisticated specialty care to substantial access gaps; affordability, urbanization, local manufacturing capacity, and clinician education are central considerations. Latin America is influenced by public-private care segmentation, uneven reimbursement, and growing metabolic-disease burdens. The Middle East shows strong investment in modern clinical services alongside differences in procurement, prevention programs, and specialist availability. Africa requires attention to essential-medicine access, diagnostic capacity, supply continuity, and task-shared chronic-care delivery.

Group Insights: Policy Blocs and Health-System Priorities

ASEAN markets require adaptable approaches because regulatory procedures, reimbursement structures, and healthcare capacity vary widely across member states. BRICS countries present large and diverse patient populations, but access is differentiated by public procurement, domestic production, insurance coverage, and regional inequality. The European Union emphasizes coordinated regulatory standards while retaining national decisions on pricing and reimbursement. G7 systems generally have strong clinical infrastructure and rigorous evidence expectations, with affordability and budget impact remaining important. GCC countries often combine centralized purchasing or sophisticated private care with substantial investment in chronic-disease management. NATO members are not a single healthcare market, but shared resilience concerns make supply security, continuity planning, and emergency logistics relevant across participating health systems.

Country Insights: Diverse Adoption and Access Conditions

The United States is shaped by private and public coverage design, prescribing controls, obesity-care policy, and supply management. Canada reflects provincial reimbursement, public formularies, and specialist access differences. Mexico and Brazil combine expanding metabolic-care needs with unequal insurance and public-system access. In Europe, Germany, France, Italy, Spain, and the United Kingdom differ in reimbursement, prescribing pathways, primary-care capacity, and health-technology assessment practices. Russia faces distinct procurement, regulatory, and supply-chain conditions. China and India require attention to large patient populations, urban-rural disparities, affordability, local production, and rapidly developing chronic-care infrastructure. Japan emphasizes structured specialist and primary-care management within a mature regulatory environment. South Korea combines advanced digital health capabilities with active management of metabolic disease. Australia is influenced by national subsidy arrangements, prescribing criteria, geographic access, and strong medication-safety oversight.

Priorities for Leaders: Strengthen Access, Evidence, and Execution

Industry leaders should align product strategy with approved indications, local reimbursement requirements, and clinically meaningful outcomes rather than relying on broad demand assumptions. They should invest in patient support that improves titration, injection technique, persistence, and adverse-event communication; build resilient temperature-controlled supply networks; and maintain clear shortage-response procedures. Evidence programs should address diverse populations, real-world effectiveness, safety, quality of life, and health-system outcomes. Regional operating models should be tailored to regulatory and procurement realities, while AI adoption should proceed through validated, auditable applications with strong privacy and human-governance controls.

Research Methodology: Evidence-Based Market Assessment

This executive summary uses the specified product category and required geographic groupings as an analytical framework. It synthesizes established therapeutic uses, healthcare-system characteristics, regulatory considerations, access determinants, clinical-practice trends, supply-chain requirements, and responsible technology applications. Regional, group, and country observations are qualitative and comparative; they do not represent market estimates, market shares, forecasts, or company-specific assessments. A full primary study would validate these themes through interviews with clinicians, pharmacists, payers, regulators, procurement stakeholders, and patients, supported by systematic review of labeling, guidelines, reimbursement policies, safety communications, and peer-reviewed evidence.

Conclusion: Competing Through Patient-Centered Reliability

The outlook for liraglutide injection depends on how effectively stakeholders translate clinical evidence into accessible, safe, and sustainable care. Success will require reliable supply, appropriate patient selection, practical support for long-term use, credible outcomes evidence, and close alignment with national regulation and reimbursement. Regional diversity means that a single global approach is unlikely to be effective. Leaders that combine clinical rigor, operational resilience, responsible digital tools, and patient-centered delivery will be best positioned to navigate the evolving treatment environment.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Liraglutide Injection Market, by Indication
7.1. Introduction
7.2. Obesity
7.2.1. Class I
7.2.2. Class II
7.2.3. Class III
7.3. Type 2 Diabetes
7.3.1. Adults
7.3.2. Pediatrics
8. Liraglutide Injection Market, by Dosage Strength
8.1. Introduction
8.2. 0.6 Mg
8.3. 1.2 Mg
8.4. 1.8 Mg
9. Liraglutide Injection Market, by Packaging Type
9.1. Introduction
9.2. Pre Filled Pen
9.3. Single Dose Vial
10. Liraglutide Injection Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Private
10.2.2. Public
10.3. Online Pharmacy
10.3.1. Manufacturer Portal
10.3.2. Third Party
10.4. Retail Pharmacy
10.4.1. Chain
10.4.2. Independent
11. Liraglutide Injection Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General
11.2.2. Specialty
11.3. Home Care
11.3.1. Nurse Administration
11.3.2. Self Administration
11.4. Hospitals
11.4.1. Private
11.4.2. Public
12. Liraglutide Injection Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Liraglutide Injection Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Liraglutide Injection Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Amgen Inc.
16.2. Apino Pharma Co., Ltd.
16.3. AstraZeneca PLC
16.4. Bachem Americas, Inc.
16.5. Biocon Limited
16.6. Chengdu Shengnuo Biopharm Co., Ltd.
16.7. Dr. Reddy's Laboratories Ltd.
16.8. Eli Lilly and Company
16.9. Hybio Pharmaceutical Co., Ltd.
16.10. Intas Pharmaceuticals Ltd.
16.11. Novo Nordisk A/S
16.12. Pfizer Inc.
16.13. Sanofi
16.14. Senova Technology Co., Ltd.
16.15. Suzhou Tianma Pharma Group Co., Ltd.
16.16. Teva Pharmaceutical Industries Ltd.
16.17. Tonghua Dongbao Pharmaceutical Co., Ltd.
16.18. Wockhardt Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Liraglutide Injection Market, Years Considered for the Study
FIGURE 2. Global Liraglutide Injection Market, Research Design
FIGURE 3. Global Liraglutide Injection Market, Research Framework
FIGURE 4. Global Liraglutide Injection Market, Data Triangulation
FIGURE 5. Global Liraglutide Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Liraglutide Injection Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Liraglutide Injection Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Liraglutide Injection Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 9. Global Liraglutide Injection Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Liraglutide Injection Market Size, by Packaging Type, 2025 vs 2032 (%)
FIGURE 11. Global Liraglutide Injection Market Size, by Packaging Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Liraglutide Injection Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Liraglutide Injection Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Liraglutide Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Liraglutide Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Liraglutide Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Liraglutide Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Liraglutide Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Liraglutide Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Liraglutide Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Liraglutide Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Liraglutide Injection Market Segmentation & Coverage
TABLE 2. Global Liraglutide Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Obesity Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Obesity Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Obesity Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Class I Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Class I Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Class I Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Class II Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Class II Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Class II Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Class III Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Class III Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Class III Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Type 2 Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Type 2 Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Type 2 Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Pediatrics Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Pediatrics Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Pediatrics Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 26. Global 0.6 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global 0.6 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global 0.6 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global 1.2 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global 1.2 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global 1.2 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global 1.8 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global 1.8 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global 1.8 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 36. Global Pre Filled Pen Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Pre Filled Pen Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Pre Filled Pen Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Single Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Single Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Single Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 43. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Private Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Private Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Private Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Public Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Public Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Public Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Manufacturer Portal Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Manufacturer Portal Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Manufacturer Portal Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Third Party Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Third Party Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Third Party Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Chain Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Chain Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Chain Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Independent Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Independent Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Independent Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global General Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global General Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global General Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Specialty Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Specialty Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Specialty Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Nurse Administration Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Nurse Administration Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Nurse Administration Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Self Administration Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Self Administration Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Self Administration Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Private Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Private Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Private Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Public Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Public Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Public Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Liraglutide Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Liraglutide Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 113. North America Liraglutide Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. North America Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 115. North America Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 116. North America Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 117. North America Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 118. North America Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 119. North America Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. North America Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 121. North America Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 122. North America Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 123. North America Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. North America Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 125. North America Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 126. North America Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 127. Latin America Liraglutide Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Latin America Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 129. Latin America Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 130. Latin America Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 131. Latin America Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 132. Latin America Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 133. Latin America Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. Latin America Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 135. Latin America Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 136. Latin America Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 137. Latin America Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Latin America Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 139. Latin America Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 140. Latin America Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 141. Europe Liraglutide Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Europe Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 143. Europe Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 144. Europe Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 145. Europe Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 146. Europe Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 147. Europe Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Europe Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 149. Europe Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 150. Europe Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 151. Europe Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Europe Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 153. Europe Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 154. Europe Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 155. Middle East Liraglutide Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Middle East Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 157. Middle East Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 158. Middle East Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 159. Middle East Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 160. Middle East Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 161. Middle East Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Middle East Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 163. Middle East Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 164. Middle East Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 165. Middle East Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Middle East Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 167. Middle East Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 168. Middle East Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 169. Africa Liraglutide Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Africa Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 171. Africa Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 172. Africa Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 173. Africa Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 174. Africa Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 175. Africa Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. Africa Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 177. Africa Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 178. Africa Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 179. Africa Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Africa Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 181. Africa Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 182. Africa Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 183. Global Liraglutide Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. ASEAN Liraglutide Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. ASEAN Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 186. ASEAN Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 187. ASEAN Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 188. ASEAN Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 189. ASEAN Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 190. ASEAN Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. ASEAN Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 192. ASEAN Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 193. ASEAN Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 194. ASEAN Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. ASEAN Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 196. ASEAN Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 197. ASEAN Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 198. GCC Liraglutide Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. GCC Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 200. GCC Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 201. GCC Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 202. GCC Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 203. GCC Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 204. GCC Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. GCC Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 206. GCC Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 207. GCC Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 208. GCC Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. GCC Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 210. GCC Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 211. GCC Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 212. European Union Liraglutide Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. European Union Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 214. European Union Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 215. European Union Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 216. European Union Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 217. European Union Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 218. European Union Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. European Union Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 220. European Union Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 221. European Union Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 222. European Union Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. European Union Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 224. European Union Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 225. European Union Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 226. BRICS Liraglutide Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. BRICS Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 228. BRICS Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 229. BRICS Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 230. BRICS Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 231. BRICS Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 232. BRICS Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. BRICS Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 234. BRICS Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 235. BRICS Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 236. BRICS Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. BRICS Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 238. BRICS Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 239. BRICS Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 240. G7 Liraglutide Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 241. G7 Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 242. G7 Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 243. G7 Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 244. G7 Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 245. G7 Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 246. G7 Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. G7 Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 248. G7 Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 249. G7 Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 250. G7 Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. G7 Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 252. G7 Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 253. G7 Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 254. NATO Liraglutide Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. NATO Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 256. NATO Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 257. NATO Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 258. NATO Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 259. NATO Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 260. NATO Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. NATO Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 262. NATO Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 263. NATO Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 264. NATO Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. NATO Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 266. NATO Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 267. NATO Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 268. Global Liraglutide Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 269. United States Liraglutide Injection Market Size, 2017-2032 (USD Million)
TABLE 270. United States Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 271. United States Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 272. United States Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 273. United States Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 274. United States Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 275. United States Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. United States Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 277. United States Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 278. United States Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 279. United States Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. United States Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 281. United States Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 282. United States Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 283. Canada Liraglutide Injection Market Size, 2017-2032 (USD Million)
TABLE 284. Canada Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 285. Canada Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 286. Canada Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 287. Canada Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 288. Canada Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 289. Canada Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. Canada Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 291. Canada Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 292. Canada Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 293. Canada Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. Canada Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 295. Canada Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 296. Canada Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 297. Mexico Liraglutide Injection Market Size, 2017-2032 (USD Million)
TABLE 298. Mexico Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 299. Mexico Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 300. Mexico Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 301. Mexico Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 302. Mexico Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 303. Mexico Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 304. Mexico Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 305. Mexico Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 306. Mexico Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 307. Mexico Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Mexico Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 309. Mexico Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 310. Mexico Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 311. Brazil Liraglutide Injection Market Size, 2017-2032 (USD Million)
TABLE 312. Brazil Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 313. Brazil Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 314. Brazil Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 315. Brazil Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 316. Brazil Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 317. Brazil Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 318. Brazil Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 319. Brazil Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 320. Brazil Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 321. Brazil Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Brazil Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 323. Brazil Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 324. Brazil Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 325. United Kingdom Liraglutide Injection Market Size, 2017-2032 (USD Million)
TABLE 326. United Kingdom Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 327. United Kingdom Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 328. United Kingdom Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 329. United Kingdom Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 330. United Kingdom Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 331. United Kingdom Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 332. United Kingdom Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 333. United Kingdom Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 334. United Kingdom Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 335. United Kingdom Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. United Kingdom Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 337. United Kingdom Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 338. United Kingdom Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 339. Germany Liraglutide Injection Market Size, 2017-2032 (USD Million)
TABLE 340. Germany Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 341. Germany Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 342. Germany Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 343. Germany Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 344. Germany Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 345. Germany Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 346. Germany Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 347. Germany Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 348. Germany Liraglutide Injection Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 349. Germany Liraglutide Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 350. Germany Liraglutide Injection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 351. Germany Liraglutide Injection Market Size, by Home Care, 2017-2032 (USD Million)
TABLE 352. Germany Liraglutide Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 353. France Liraglutide Injection Market Size, 2017-2032 (USD Million)
TABLE 354. France Liraglutide Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 355. France Liraglutide Injection Market Size, by Obesity, 2017-2032 (USD Million)
TABLE 356. France Liraglutide Injection Market Size, by Type 2 Diabetes, 2017-2032 (USD Million)
TABLE 357. France Liraglutide Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 358. France Liraglutide Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 359. France Liraglutide Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 360. France Liraglutide Injection Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 361. France Liraglutide Injection Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 362. France Liraglutide Injection Market Size

Companies Mentioned

  • Amgen Inc.
  • Apino Pharma Co., Ltd.
  • AstraZeneca PLC
  • Bachem Americas, Inc.
  • Biocon Limited
  • Chengdu Shengnuo Biopharm Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Hybio Pharmaceutical Co., Ltd.
  • Intas Pharmaceuticals Ltd.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi
  • Senova Technology Co., Ltd.
  • Suzhou Tianma Pharma Group Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Wockhardt Ltd.

Related Topics

Related Reports

Liraglutide and Semaglutide - Global Strategic Business Report - Product Image

Liraglutide and Semaglutide - Global Strategic Business Report

  • Report
  • 451 Pages
  • Global
From
GLP-1 Injection Market - Global Forecast 2026-2032 - Product Image

GLP-1 Injection Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Liraglutide Market Report 2026 - Product Image

Liraglutide Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Liraglutide and Semaglutide Market Report 2026 - Product Image

Liraglutide and Semaglutide Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Liraglutide and Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis by Application, End User, Distribution Channel, Dosage Form - Product Image

Liraglutide and Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis by Application, End User, Distribution Channel, Dosage Form

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.